W
William G. Honer
Researcher at University of Queensland
Publications - 5
Citations - 746
William G. Honer is an academic researcher from University of Queensland. The author has contributed to research in topics: Patient advocacy & Psychosis. The author has an hindex of 3, co-authored 5 publications receiving 486 citations. Previous affiliations of William G. Honer include University of British Columbia & University of Toronto.
Papers
More filters
Journal ArticleDOI
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D. Howes,Robert A. McCutcheon,Ofer Agid,Andrea de Bartolomeis,Nico J.M. van Beveren,Michael L. Birnbaum,Michael A P Bloomfield,Rodrigo A. Bressan,Robert W. Buchanan,William T. Carpenter,David J. Castle,Leslie Citrome,Zafiris J. Daskalakis,Michael Davidson,Richard J. Drake,Serdar M. Dursun,Bjørn H Ebdrup,Helio Elkis,Peter Falkai,W. Wolfgang Fleischacker,Ary Gadelha,Fiona Gaughran,B. Glenthøj,Ariel Graff-Guerrero,Jaime Eduardo Cecílio Hallak,William G. Honer,James L. Kennedy,Bruce J. Kinon,Stephen M. Lawrie,Jimmy Lee,F. Markus Leweke,James H. MacCabe,Carolyn B. McNabb,Herbert Y. Meltzer,Hans-Jürgen Möller,Shinchiro Nakajima,Christos Pantelis,Tiago Reis Marques,Gary Remington,Susan L. Rossell,Bruce R. Russell,Cynthia Siu,Takefumi Suzuki,Iris E. C. Sommer,David Taylor,Neil Thomas,Alp Üçok,Daniel Umbricht,James T.R. Walters,John M. Kane,Christoph U. Correll +50 more
TL;DR: The authors present consensus guidelines that operationalize criteria for determining and reporting treatment resistance, adequate treatment, and treatment response, providing a benchmark for research and clinical translation in schizophrenia.
Journal ArticleDOI
Consensus statement on the use of clozapine during the COVID-19 pandemic.
Dan Siskind,William G. Honer,Scott R. Clark,Christoph U. Correll,Alkomiet Hasan,Oliver Howes,John M. Kane,Deanna L. Kelly,Robert Laitman,Jimmy Lee,James H. MacCabe,Nicholas Myles,Jimmi Nielsen,Peter F. Schulte,David Taylor,Hélène Verdoux,Amanda J. Wheeler,Oliver Freudenreich +17 more
TL;DR: An expert advisory subgroup of the Treatment Response and Resistance in Psychosis working group developed the following background, recommendations and rationale as a consensus statement: clozapine prescribing guidance and facilitate regulatory agencies modifying laboratory monitoring and/or dispensing requirements.
Journal ArticleDOI
Increased head circumference in schizophrenia.
Anne S. Bassett,Anne S. Bassett,Eva W.C. Chow,Eva W.C. Chow,Alison Bury,Alison Bury,Faizal Ali,Faizal Ali,Claire A.H. Haylock,Claire A.H. Haylock,Geoffrey N. Smith,Geoffrey N. Smith,Jocelyne S. Lapointe,Jocelyne S. Lapointe,William G. Honer,William G. Honer +15 more
TL;DR: The hypothesis was that schizophrenic subjects would have smaller than normal head sizes, and that microcephaly ( 97th centile) would be diagnosed.
Effectsofendurancetrainingonbrainstructuresinchronicschizophrenia patients and healthy controls
B. Malchow,Daniel Keeser,Katriona Keller,Alkomiet Hasan,Boris-Stephan Rauchmann,Hiroshi Kimura,Thomas Schneider-Axmann,Peter Dechent,Oliver Gruber,William G. Honer,Ursula Hillmer-Vogel,Andrea Schmitt,Andree Niklas +12 more
Journal ArticleDOI
Clozapine and COVID-19: The authors respond.
Dan Siskind,Dan Siskind,William G. Honer,Scott R. Clark,Christoph U. Correll,Alkomiet Hasan,Oliver Howes,John M. Kane,Deanna L. Kelly,Robert Laitman,James S. Lee,James H. MacCabe,Nicholas Myles,Jimmi Nielsen,Peter F. Schulte,David Taylor,Hélène Verdoux,Amanda Wheeler,Oliver Freudenreich +18 more
TL;DR: The authors and journal are complimented for ensuring the “Consensus statement on the use of clozapine during the COVID-19 pandemic” was published in a timely fashion.